Two years ago, Gyanendra Nath Singh was tasked with overseeing India's drug regulatory agency. Despite the US having temporarily suspended a suite of trials in India and banned drug imports from several manufacturers there over the last couple of years, Singh says progress is being made. Killugudi Jayaraman reports.